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The present study investigates the influence of COPD on attention functions, learning, and
logical thinking.
Therefore, 60 COPD patients and 60 healthy controls were recruited into a cross-sectional
study and underwent extensive neuropsychological testing. The Attention Network Test was
used for assessment of tonic and phasic alertness, orienting, and executive attention. Logical
thinking and learning were determined with the Standard Progressive Matrices and the Verbal
and Nonverbal Learning Test, respectively. Significant group differences were found in phasic
alertness (pZ 0.001) and orienting (pZ 0.01) but not in executive attention. In addition over-
all reaction time was significantly slower in the COPD group (pZ 0.001). Further group differ-
ences were found in verbal (p< 0.001) and visual learning (p< 0.001) and logical thinking
(p< 0.001). Regression analysis revealed significant correlations for age (pZ 0.024) and blood
carbon dioxide levels (pZ 0.043) in reaction time, a correlation for age and orienting
(pZ 0.019) and finally for age (pZ 0.011) as well as for blood carbon dioxide values
(pZ 0.048) and performance in logical thinking.
Results are indicating a global impairment in cognitive functions of COPD patients which is
negatively influenced by accelerated aging and increasing with disease severity.
ª 2009 Elsevier Ltd. All rights reserved.gischer Fachdienst, Assista
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Previous studies have shown that patients with Chronic
Obstructive Pulmonary Disease (COPD) have various cogni-
tive impairments. Deficits were primarily reported for
verbal learning and memory1 evaluated with the Mental
Deterioration Battery and 14 indexes of verbal memory,
where defective retrieval and recognition mechanisms.
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subjects with comparable age and educational level, but
also for other cognitive functions like orientation measured
with the Short Test of Mental Status on ten COPD patients
and age-matched healthy controls,2 or fluid intelligence3 in
the Culture Fair (CF) Intelligence Test (Institute for
Personality and Ability Testung (IPAT) Champaign, IL) on 29
COPD patients, and semantic fluency in thirty patients
versus 21 healthy controls.4 Slower reaction time and
attentional deficits were found for simple, selective and
sustained attention but not for divided attention, and
vigilance measured with the German Test Batterie fu¨r
Aufmerksamkeitspru¨fung (TAP) in 32 COPD patients.5
Deductive/logical thinking and executive functions are
regularly impaired and show an accelerated age-related
progression. Frontal-type cognitive decline and frontal
hypoperfusion seem to be a prevalent aspect of brain
performance as it was shown in a comparison of ten normal
subjects, 15 COPD patients with and 18 without hypoxemia
in a SPECT study6 on the basis of Simple Analogies, Semantic
Word Fluency, Temporal Rules Induction and the Mental
Deterioration Battery (MDB) which includes 8 tests with
high reliability. The cognitive problems are also responsible
for limitations in activities of daily living as it was shown in
149 patients in scores of basic/instrumental activities of
daily living (BADL/IADL),7 and coping skills, shown by the
lack of memory for their symptoms in thirty patients who
recorded their dyspnoea and fatigue intensity scores.8 The
exact pattern and course of the cognitive decline in
patients with COPD is still not understood. The aim of the
present study is, therefore, a more in-depth analysis of
cognitive dysfunctions with a more detailed exploration of
attention functions in COPD patients. We assume that the
deceleration of reaction time, which represents tonic
alertness is a replicable effect of general cognitive decline,
and that brain functions putatively associated within theTable 1 Socio-demographic and medical characteristics of the
COPD
Gender 24 F/36 M
Age 63.2, range 37e83, S
FEV1% pred. 36.4, range 18e71, S
FEV1/VCmax(%) pred. 52.1, range 34e70, S
Mean PaO2 59.7, range 42e87.7,
Mean PaCO2 42.9, range 32.3e70.
Mean SO2 90.3, range 78.7e96.
C-reactive protein 0.65, range 0.02e4.3
Leukocytes 10.59, range 4.42e18
Medication Percentage of group
receiving therapy
Longterm anticholinergics 94%
Systemic Corticosteroids 77%
Theophylline 15%
Inhalative Corticosteroids (ICS) 5%
Longterm beta-2-mimetics (LABA) 6%
Combination compound ICS/LABA 58%
Short term Bronchodilators 54%
Abbreviations: FEV1%Z forced expiration volume in one second, VCm
PaCO2Z arterial carbon dioxide pressure.frontal lobe like central-executive control functions and
logical thinking are diminished in COPD patients
predominantly.
Tests perceptive to those functions, like the Standard
Matrices Test (SPM) that was used in this study, should
articulate group differences sharper than memory tests and
attention tests.
Methods
Subjects
Thirty patients with diagnosis of COPD based on the criteria
of the American Thoracic Society were consecutively
recruited in an inpatient setting after admission to a chest
clinic (Department of Pneumology at the Landesklinik
Hochegg in Austria). Twenty-four of them were women. Re-
examination of pre-bronchodilatation lung function and
measurement of partial pressure of oxygen (PaO2) and
carbon dioxide (PaCO2) for this study were carried out in an
inpatient setting within the smallest possible delay to
neuropsychological testing. These values might have
differed slightly from post-bronchodilatation values used
for the diagnosis of COPD. However, lung function exami-
nation was performed in all patients receiving prescribed
therapy. Gender and important clinical variables as medi-
cation were registered (Table 1).
Education was registered in categories for elementary
school (13.3%), high school (80%), university entrance
diploma (5%), and academic education (1.7%).
For group comparison data for Attention Testing of 60
age- and gender-matched healthy controls were obtained.
Participants in the control group had no history of pulmo-
logical diseases and therefore no lung function and blood
chemistry assessment was performed. Published test normsCOPD and the Control group.
Controls/Reference
24 F/36 M
td. dev.: 9.8 63.5 range 37e84, Std. dev.: 8.3
td. dev: 12.5 Ref 100%
td. dev: 10.6 Ref 100%
Std.dev: 10.2 Ref 95 mmHg
2, Std.dev: 6.9 Ref 40 mmHg
9, Std.dev: 4.2 Ref 97%
4, Std.dev: 0.79 Ref <0.8 to < 1.0 mg/dl
.94, Std.dev: 3.31 Ref 4.8 to 10.8 c/nl
axZmaximum vital capacity, PaO2Z arterial oxygen pressure,
Figure 2 The four ANT warning conditions: (a) fixation cross,
(b) centre cue, (c) double cue, (d) spatial cue.
54 M. Klein et al.for learning and deductive/logical thinking as well as for
vocabulary/knowledge were available with test manuals.
Exclusion criteria for this study were cardiovascular or
cerebrovascular diseases, diagnosis of a mental disorder
according to DSM-IV, and a score lower than 26 in the Mini
Mental State Examination. However in none of the subjects
a score lower to 26 was detected. Informed consent was
obtained by all subjects and the study was approved by the
Regional Research Ethics committee.
Procedures
Attention was measured with the Attention Network Test.9
Additionally, patients with COPD were examined with
a short form of the Standard Progressive Matrices, the
Verbal Learning Test, the Nonverbal Learning Test and
a German Vocabulary Test to determine impairments in
other cognitive functions.
Attention Network Test (ANT)
The ANT is a computer based choice reaction time task
which was designed for the assessment of alerting, orient-
ing, and executive functions of attention.10 Participants
were required to identify whether a central arrow pre-
sented on a computer screen points left or right by pressing
the equivalent button on the keyboard (across all condi-
tions response with one hand only). This target arrow was
flanked on either side by lines (neutral condition), by two
arrows in the same direction (congruent condition), or in
the opposite direction (incongruent condition). The stimuli
(one central arrow accompanied by four flankers) appeared
either above or below a fixation point. The three target
conditions are depicted in Fig. 1.
There were four warning conditions indicating the
imminent appearance and/or location of the target: (a) no
cue (only fixation cross), (b) centre cue, (c) double cue, and
(d) spatial cue (see Fig. 2).
In the alerting subtest, reaction times of no cue and
double cue conditions were analysed. As measures for the
Orienting subtest, centre cue and spatial cue conditions
were recorded. The Conflict subtest was assessed by mean
reaction times of congruent and incongruent conditions.
The ANT includes a practice block with 24 trials and three
assessment blocks with 96 trials each (total duration
30 min). During the practice block, participants get imme-
diate feedback about the accuracy of their responses. For
details on the administration of the ANT see Appendix 1.
Standard Progressive Matrices (SPM)
A short form of the SPM was used to determine fluid intel-
ligence. The SPM is part of the Vienna Testsystem11 andFigure 1 The three ANT target conditions: (a) neutral,
(b) congruent, (c) incongruent.contains 32 items. Participants are required to complete
a design or a matrix with one missing part in each of 32
figures. In order to show good logical thinking regularities in
patterns have to be detected in a multiple choice test form
by deductive reasoning. For details on the administration of
the SPM see Appendix 2.
Verbal and Nonverbal Learning Test (VLT and NVLT)
Learning and memory were assessed with the VLT which is
part of the Vienna Testsystem.11 The VLT (verbal learning)
and NVLT (visual learning) consist of 120 items displayed
consecutively while only 8 items (non-sense words in VLT
and geometrical figures in NVLT) are shown several times.
These recurring items are to be recognized and memorized
during 5 serial learning trials where every item must be
categorized as new or already shown. For details on the
administration of the VLT and NVLT see Appendix 3.
Statistical analysis
Statistical calculations were performed with SPSS for Mac
v11.0. For all ANT variables, means were calculated from
individual reaction time medians.
t-Tests were used to elucidate group differences. In
addition to statistical significance testing, effect sizes
(bias-corrected) were calculated according to Hedges.13
Regression analyses were performed to determine whether
clinical characteristics of the COPD patients predict
cognitive impairments. As cognitive impairment could be
seen in test scores below the average of the age- and sex-
matched control group, regression analysis would only yield
model data for cognitive impairment in the COPD group
while the control group would not show impairments by
definition and was therefore not subjected to regression
analysis. Possible predictors for cognitive impairment in
COPD patients were chosen evaluating the entire amount of
clinical information available for the studied group omitting
variables that showed empty cases. For this purpose
complete data sets comprised forced expiratory volume
FEV1% of pred. and the ratio FEV1%/VCmax% (vital capacity)
of pred., PaO2 (blood oxygen), PaCO2 (blood carbon
dioxide), C-reactive protein (CRP) and leukocyte count.
The amount of predictors was limited to an appropriate
number for the group size of 60 COPD patients. A model
containing age-related impact and disease severity was
compared with models containing oxidative effects such as
PaO2 and PaCO2 and inflammatory effects such as CRP and
Impact of chronic obstructive pulmonary disease (COPD) on attention functions 55leukocyte count. Three blocks of variables entered into
a hierarchical analysis were built: In model A) age and FEV1
related parameters were chosen as evident basis for
cognitive performance and disease progression. Both par-
ametres are well known predictors for progression of
disease. To test for the influence of oxidative and inflam-
matory effects on cognitive performance within the COPD
group PaO2 and PaCO2 were included in model B) and model
C) comprised CRP and leukocytes for comparison.
A) Age, FEV1% of pred., FEV1%VCmax[%] of pred.
B) PaO2 (blood oxygen), PaCO2 (blood carbon dioxide)
C) C-reactive protein (CRP) and leukocytesResults
All values for lung function and blood gas analysis were
obtained under current therapy and before bronchodilata-
tion. Liquid oxygen therapy was provided to patients with
hypoxemia (PaO2< 55 mmHg) to obtain arterial oxygen
saturation 95%.14,15
Neuropsychological test results of group comparisons
between the COPD group and controls are depicted in Table 2.Table 2 Results of neuropsychological testing separated for pa
methodological details.)
COPD mean (SD) Controls me
ANT
Relative alerting
(% of mean)
4.2 (5.2) 7.1 (4.2)
No cue (ms) 680 (121) 622 (110)
Double cue (ms) 651 (121) 576 (114)
Relative orienting
(% of mean)
3.2 (4.3) 5.5 (5.2)
Centre cue (ms) 657 (120) 588 (113)
Spatial cue (ms) 637 (114) 555 (107)
Relative conflict (% of mean) 11.8 (5.6) 11.9 (5.3)
Incongruent (ms) 714 (127) 640 (128)
Congruent (ms) 632 (118) 563 (111)
Overall reaction
time (ms)
649 (113) 583 (110)
Accuracy (%) 96.7 (3.9) 98.3 (1.7)
VLT
Corr. YES (percentile) 40.9 (25.6) 50 (10)
False YES (percentile) 35.6 (32.6) 50 (10)
Diff. corr./false (percentile) 31.9 (27.1) 50 (10)
NVLT
Corr. YES (percentile) 55.7 (25.7) 50 (10)
False YES (percentile) 21.3 (24.6) 50 (10)
Diff. corr./false (percentile) 23.8 (20.3) 50 (10)
SPM
Result (percentile) 9.9 (13.2) 50 (10)
Note. (*p< 0.05, **p< 0.01).
Abbreviations: ANTZ Attention Network Test, VLTZ Verbal Learning
sive Matrices.Significant differences between the COPD group and
healthy controls could be demonstrated in several atten-
tion components yielding a study power of 90% in reaction
time tests. Hypoxemia per-se could have played a role and
was evaluated by exclusion of 14 affected cases in the
COPD group. After this procedure the neuropsychological
profile was not altered essentially except for correct YES-
answers in the VLT test missing significance slightly
(pZ 0.09) but not for the overall VLT or any other results.
Therefore the complete data set of the COPD group was
preserved for further analysis with hypoxemia as an
expression of disease severity.
Accuracy of response behaviour regarding correctness of
left-/right-decisions was significantly lower in the COPD
group. Additionally overall reaction time was significantly
higher in the COPD group compared to healthy controls.
While in the ANT the alarm effect and the orientation
effect was significantly lower in the COPD group no signif-
icant differences were found in the conflict effect.
Comparing verbal and nonverbal learning abilities to
standard norm data published with the test manuals COPD
patients showed significantly more false positive recognition
claims for both verbal and visual learning material. True
positiveswere correctly recognized to normal extent in visualtients with COPD and healthy controls. (See Appendices for
an (SD) t-score Effect sizes ES (Confidence interval)
3.44** 0.61 (0.98 to 0.24)
2.61* 0.48 (0.84 to 0.12)
0.06 0.02 (0.38 to 0.34)
3.25** 0.59 (0.22 to 0.95)
2.98** 0.53 (0.89 to 0.16)
2.56* 0.47 (0.83 to 0.10)
3.18* 0.59 (0.96 to 0.23)
4.79** 0.88 (1.26 to 0.51)
1.57 0.29 (0.07 to 0.65)
8.24** 1.52 (1.92 to 1.11)
9.12** 1.63 (2.04 to 1.21)
21.89** 3.4 (3.96 to 2.84)
Test, NVLTZ Nonverbal Learning Test, SPMZ Standard Progres-
Figure 3 Magnitude of effect sizes in group comparisons show predominant deficits in functions of central control like accuracy
of response behaviour and especially deductive/logical thinking. AlZ Alerting effect, OrZOrienting effect, CoZ Conflict effect,
GrMnZ ANT GrandMean, AccZ ANT Accuracy, VLT-tpZ VLT true positives, VLT-fpZ VLT false positives, VLT-resZ VLT overall
results, NVLT-tpZ NVLT true positives, NVLT-fpZ NVLT false positives, NVLT-resZ NVLT overall results, SPR-resZ SPM overall
results.
56 M. Klein et al.material but not in verbal material. Generally, a tendency to
answer with ‘‘yes’’ was observed. However, when looking at
results in fluid intelligence a substantial difference between
study groups could be observed, since COPD patients scored
significantly lower in SPM results (Fig. 3).
Regression analyses were calculated for all neuro-
psychological test values and several independent factors
of lung function, blood oxygenation and inflammation
parameters.
Results for the complete data set of the COPD group are
displayed in Table 3.
Significant effects were found for age and blood carbon
dioxide levels in the overall reaction time (ANT GrandMean)
as well as for fluid intelligence (SPM percentile) (Figs. 4e7).Table 3 Results of the hierachical regression analysis.
Adjusted R Square F
ANT GrandMean
Model b
DR2Z 0.08 0.12 2.52
Orienting (effect size)
Model a
DR2Z 0.14 0.09 2.81
SPM results
t-score
Model b
DR2Z 0.08 0.17 2.93
Abbreviation: PaCO2Z arterial carbon dioxide pressure.Age played a significant role for the effect size of ori-
enting (Fig. 8).
Discussion
In the present study patients suffering from COPD show
significant cognitive deficits compared to healthy age-
matched controls. Overall reaction time (GrandMean),
measured with the Attention Network Time (ANT), was
significantly slower in COPD patients compared with age-
matched healthy controls. Phasic alertness was assessed in
the same test, namely as time gained due to an alarm signal
prior to the reaction stimulus and led to significantly lower
results in the COPD group, where patients could not profitp Sign Predictors beta p
Age 0.31 0.024
PaCO2[mmHg] 0.31 0.043
0.04
Age 0.32 0.019
0.048
Age 0.36 0.011
PaCO2[mmHg] 0.33 0.048
0.023
Figure 4 Partial regression plot of overall reaction time and
age in the COPD group. rZ 0.285, pZ 0.024.
Figure 5 Partial regression plot of overall reaction time and
PaCO2 in the COPD group. rZ 0.22, pZ 0.043.
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Neuropsychological performance that represents the mode
of working of the brain almost always comprises an effect
of orientation in space or a spatial component.
There are abundant number of publications in the scien-
tific literature on associations between the left hand and the
right hand side of space and magnitudes, which, on
a phenomenal level, do not have any spatial dimension. To
name a few, the spatialenumerical association of response
codes (SNARC) effect is represented in faster reaction times
on left hand responses when reacting on low numbers versus
faster responses through the right hand when reacting on
high numbers in reaction time tasks. Corresponding effects
can be seen as SMARC effect for musical tasks when reacting
on bass versus high pitch tones and other effects when
judging short versus long time durations through the right or
the left hand (STEARC effect). For an overview see 16. The
handling of spatial information by the brain is also assessed in
the ANT,whichwas used in this study. By displaying the alarm
signal in the same place as the succeeding reaction stimulus
in one part of the tasks and in a distant place of the screen in
another part of the tasks allowed the calculation of the ori-
enting time in every group. COPD patients gained signifi-
cantly less reaction time to near spatial alarm signals and
showed less orientation time during their slower responses.
Finally, the results in executive attention showed no signif-
icant differences between the COPD group and age-matched
controls, suggesting that the slower overall reaction time in
the COPD group seems primarily to be adapted to compen-
sate for filtering contradictory and conflicting stimulus
information. Nevertheless, COPD patients still made signifi-
cantly more mistakes in their response behaviour and were
less accurate. In contrary to those attentional networks,
memory and particularly fluid intelligence, which appear
impaired to some degree, crystallized intelligence (knowl-
edge, vocabulary) remains intact.
The magnitude of effect sizes in group comparisons
concerning the cognitive profile of COPD patientscorroborates findings of Incalzi et al.7 showing predominant
deficits in functions of central control like accuracy of
response behaviour and especially deductive/logical
thinking.
However, there are some limitations in our study due to
the partial use of published norm data in the psychological
testing. Furthermore smoking history could have been
assessed only by asking the participants retrospectively and
was discarded due to the expected inaccuracy of this data
compared with prospective studies, especially regarding
the influence of cognitive impairment on statements in
COPD patients. However, ninety percent of patients
suffering from COPD usually show a smoking history and
comparing the COPD group with controls without history of
pulmological disorders and other signs of diseases seems to
be representative for what is typically seen in specialized
institutions treating COPD patients.
In this study impairments were found in a wide-range for
central-nervous networks of attention in the COPD group.
Here, for the first time we could demonstrate an analysis of
separate attentional networks that result in significant
differences between COPD and controls in orienting effects
while no differences are seen in conflict effects. Regression
analysis showed several significant correlations between
neuropsychological and physiological parameters. Though
regression analysis was performed on age-matched t-score
results in the SPM test, age still showed up as relevant
predictor of logical thinking. As outlined recently by Kirkil
et al17 an accelerated aging of the brain could be taken into
account as explanation for this differentiation of brain
performance on one hand. These effects may have played
a role in cerebral tissue as the relevant neurophysiological
basis for fluid intelligence and cognitive speed in this study.
On the other hand, various systemic effects seen in
COPD,18e23 show similarities in tissue mass alterations that
could be comparable to modification of brain parenchyma.
Tissue with high energy consumption like muscle mass is
reduced in relation to fat tissue in the glycemic
Figure 6 Partial regression plot of SPM results and age in the
COPD group. rZ0.336, pZ 0.011.
Figure 8 Partial regression plot of orientation time effect
size and age in the COPD group. rZ0.342, pZ 0.019.
58 M. Klein et al.metabolism,24,25 as vital energy storage in a critical meta-
bolic state of the organism,26,27 In the same way some parts
in brain function could be diminished as a non-critical
mechanism for basic survival in a critical metabolic state of
a systemic disease like COPD. As previously stated by Incalzi
et al.7 the cognitive status seems to be the result from
interactions of several factors also due to negative effects of
smoking and comorbid diseases, such as diabetes mellitus or
arterial hypertension. Furthermore, the results in our study
suggest that blood carbon dioxide levels predict cognitive
deficits in COPD patients, and PaCO2 levels reflect disease
severity, especially when including severe cases. From
a neuropsychological point of view results in logical thinking
(SPM results) show a particular sensitivity for this influenceFigure 7 Partial regression plot of SPM results and PaCO2 in
the COPD group. rZ0.331, pZ 0.048.because they integrate cognitive faculties on the highest
level and are therefore less robust than simpler phenomena
like attention functions. Frontal-lobe functions generally
associated with these faculties are presumed to derive from
the controlling connections to all parts of the brain that
mature late in young to adult human beings. These long
connections stemming from the frontal lobe could provide
a large surface susceptible to stressful attacks on the tissue
as described for other systemic effects.
Though there is some evidence in the literature for the
ameliorating effect on cognitive deficits under oxygen
therapy, there was no attempt to find such a therapy effect
in this study. Patients provided with oxygen could rather be
attributed to more severe disease categories and therefore
showed more progression in corresponding parameters as
cognitive decline. Nevertheless this could cover up short
term amelioration that was not analysed in this cross-
sectional study.
In terms of clinical relevance of these findings it seems
to be important to inform patients about the possible
cognitive deficits. Generally almost no participant in this
study presumed that cognitive deficits could possibly be
associated with a disease like COPD. Even more remarkable
was the fact, that none of the participants admitted that
she or he had observed any problems with memory or
thinking in the past. Education about this topic could
strengthen the acceptance to seek help in psychological
support and therapy if necessary. Situative observations of
the patients suggest that many every-day situations could
be influenced by the impairment of cognitive functions
(e.g. when impatiently pushing into the elevator while
blocking the exit for others or cyanotically leaving the clinic
carrying their prescribed oxygen mask in their hands
instead of using it etc.).
In conclusion, exact neuropsychological diagnosis and
cognitive training should be included into the clinical
routine when treating COPD patients especially in longterm
rehabilitation programs.
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Appendix 1
Each trial lasts 4000 ms and consists of five different periods.
In the first period, a fixation cross is presented for 400e
1600 ms. An additional cue is then shown for 100 ms in the
second period followed by the fixation cross (duration
400 ms) in the third period. In the fourth period, the target
arrow with flankers is shown for 1700 ms at the most. After
a response, the fixation cross is presented again in the last
period. The duration of the last period depends on the
duration of the first fixation period and the reaction time
(3500 ms first fixation periodereaction time). For data anal-
ysis, only valid trials and trials with a reaction time between
200 and 2000 ms were considered. In addition, an outlier
analysis was performed. Trials with a reaction time two
standard deviations above or below the condition mean were
not considered. Additional to condition means (calculated
from individual medians), the overall mean reaction time as
well as the accuracy (percentage of correct responses) was
recorded. Relative reaction time effects were calculated in
form of the ratio of absolute reaction time effects for alarm,
orienting and conflict in relation to the respective (cue/no-
cue or congruent/incongruent) condition mean.
Appendix 2
For the administration of the test after a short instruction,
the items are presented on a computer screen according to
their level of difficulty. The participant is required to select
one of six or eight answers which can be corrected at any
time by switching to another answer. All omitted items are
presented again at the end of the test.
The SPM has been widely used as a measure of eductive
ability e ‘‘the ability to evolve high-level constructs which
make it easier to think about complex situations and
events’’.12 Convergent validity for the SPM is good in terms
of scores on the assessment relating to scores on other
assessments that claim to measure similar traits or
constructs. Correlations with factor-analytical calculations
for intelligence tests show high values in the g-factor, often
amounting up to rZ 0.95.11
Appendix 3
The VLT and NVLT are administered on a computer where
meaningless neologisms with partly high and partly low
associations are presented for verbal learning and
geometric figures, partly symmetrical and partly irregular,
are displayed for visual learning. The participant answers
by pressing one of the two reaction buttons signaling
whether or not the item was seen before.
Regarding the validity of these tests, it was verified that
the learning procedure in the course of the testing wasmonotonous according to the Guttman Scale. This could be
affirmed to 93e97% for the highly associative or symmet-
rical items, and to 85e92% for the low associative or
irregular items.11
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